Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Journal of Clinical Immunology|March 28, 2022
Interpretation of Dihydrorhodamine-1,2,3 Flow Cytometry in Chronic Granulomatous Disease: an Atypical ExemplarAgnes Donko, Douglas B Kuhns, Margot A Cousin, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 26, 2015
Asthma-associated comorbidities in children with and without secondhand smoke exposureRegan C Pyle, Rohit Divekar, Sara M May, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 6, 2025
Sex differences in urinary mast cell mediators: Implications for diagnosing atopic and mast cell disordersValerie Jaroenpuntaruk, Sarah M Jenkins, Carin Y Smith, et al.Journal of Clinical Immunology|August 20, 2016
Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG DeficiencyTami John, Jolan E Walter, Catherina Schuetz, et al.Mayo Clinic Proceedings|February 9, 2022
The Female-Predominant Persistent Immune Dysregulation of the Post-COVID SyndromeRavindra Ganesh, Stephanie L Grach, Aditya K Ghosh, et al.Journal of Clinical Immunology|April 20, 2018
Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic ImmunodeficienciesMargot A Cousin, Matthew J Smith, Ashley N Sigafoos, et al.Mayo Clinic Proceedings|March 5, 2025
Mpox in a Patient With a Signal Transducer and Activator of Transcription 1 Gain-of-Function MutationJack W McHugh, Eric O Gomez, Omar M Abu-Saleh, et al.American Journal of Hematology|August 14, 2021
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromesEmma St Martin, Alejandro Ferrer, Abhishek A Mangaonkar, et al.The Journal of Allergy and Clinical Immunology|February 10, 2019
Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cellsJulia Bier, Geetha Rao, Kathryn Payne, et al.The Lancet. Respiratory Medicine|May 30, 2021
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean-Claude Tardif, Nadia Bouabdallaoui, Philippe L L'Allier, et al.Pageof 6